Melbourne, Australia – [July 9th, 2024] – Eyerising International is proud to announce that Tokyo Medical and Dental University will introduce the Eyerising Myopia Management Device for their myopia patients as part of their treatment options. This marks a significant milestone in the advancement of myopia management and treatment solutions.
The Eyerising Myopia Management Device utilizes patented Repeated Low-Level Red-light (RLRL) technology, offering an efficacious, safe, non-invasive, and user-friendly solution for managing myopia in patients. Myopia, or near-sightedness, has become a prevalent concern worldwide, with increasing cases among children and adolescents. The device aims to curb the progression of myopia, enhancing the quality of life for millions of individuals.
Both TMDU and Eyerising International are committed to ongoing research and development to further enhance the device’s capabilities and efficacy.
